Hu Hongfei, Zhou Ting, Qiu Yijin, Li Yuxin, Liu Wei, Meng Rui, Zhang Xueke, Ma Aixia, Li Hongchao
School of International Pharmaceutical Business.
Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China.
Ann Med Surg (Lond). 2023 Nov 7;86(1):439-455. doi: 10.1097/MS9.0000000000001455. eCollection 2024 Jan.
Surgical site infections (SSIs) are one of the most common complications after pancreaticoduodenectomy (PD); however, the global prevalence and risk factors for SSIs after PD remain unknown.
To investigate the prevalence of and risk factors for SSIs after PD.
The PubMed, Embase, Cochrane Library, Web of Science, and Science Direct databases were systematically searched from inception to 1 December 2022. Observational studies reporting adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of risk factors for SSIs in patients undergoing PD were included. Two independent reviewers in teams performed data extraction, risk of bias assessment, and level of evidence analysis. The pooled results were estimated using a random-effects model. The statistic and Q statistic were used to assess heterogeneity. Funnel plots, Egger's regression test, and the trim-and-fill method were used to determine publication bias. The primary outcomes were identifying risk factors for SSIs after PD. The secondary outcomes were the pooled prevalence rates of SSIs.
A total of 98 704 patients from 45 studies were included, and 80% of the studies were considered high quality. The estimated pooled prevalence of SSIs was 23% (0.19-0.27, =97%). The prevalence of SSIs was found to be higher in Japan and lower in USA. Preoperative biliary stenting, higher body mass index (BMI), longer operation time, postoperative pancreatic fistula, soft pancreatic texture, perioperative blood transfusion, and cardiac disease were identified as significant risk factors for the development of SSIs after PD. Additionally, broad-spectrum antibiotics were a significant protective factor against SSIs. Subgroup analysis and sensitivity analysis showed that the results were robust.
The prevalence of SSIs remains high and varies widely among regions. It is necessary to take effective preventive measures and carry out more prospective studies to further verify these results.
手术部位感染(SSIs)是胰十二指肠切除术(PD)后最常见的并发症之一;然而,PD术后SSIs的全球患病率和危险因素仍不清楚。
调查PD术后SSIs的患病率及危险因素。
系统检索PubMed、Embase、Cochrane图书馆、Web of Science和Science Direct数据库,检索时间从建库至2022年12月1日。纳入报告接受PD患者SSIs危险因素的调整优势比(OR)和95%置信区间(CIs)的观察性研究。两组独立的评审员进行数据提取、偏倚风险评估和证据水平分析。采用随机效应模型估计合并结果。使用I²统计量和Q统计量评估异质性。采用漏斗图、Egger回归检验和剪补法确定发表偏倚。主要结局是确定PD术后SSIs的危险因素。次要结局是SSIs的合并患病率。
共纳入45项研究的98704例患者,80%的研究被认为质量较高。SSIs的估计合并患病率为23%(0.19 - 0.27,I² = 97%)。发现日本SSIs的患病率较高,而美国较低。术前胆道支架置入、较高的体重指数(BMI)、较长的手术时间、术后胰瘘、胰腺质地柔软、围手术期输血和心脏病被确定为PD术后发生SSIs的重要危险因素。此外,广谱抗生素是预防SSIs的重要保护因素。亚组分析和敏感性分析表明结果可靠。
SSIs的患病率仍然很高,且在不同地区差异很大。有必要采取有效的预防措施,并开展更多前瞻性研究以进一步验证这些结果。